Alto Neuroscience Inc (ANRO)’s stock price range in the last year

While Alto Neuroscience Inc has overperformed by 2.17%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ANRO fell by -44.44%, with highs and lows ranging from $17.55 to $1.60, whereas the simple moving average fell by -48.29% in the last 200 days.

On October 23, 2024, Wedbush Downgraded Alto Neuroscience Inc (NYSE: ANRO) to Neutral. A report published by Rodman & Renshaw on October 23, 2024, Downgraded its rating to ‘Neutral’ for ANRO. Wedbush also rated ANRO shares as ‘Outperform’, setting a target price of $29 on the company’s shares in an initiating report dated September 03, 2024. TD Cowen initiated its ‘Outperform’ rating for ANRO, as published in its report on February 27, 2024. Stifel’s report from February 27, 2024 suggests a price prediction of $32 for ANRO shares, giving the stock a ‘Buy’ rating. Robert W. Baird also rated the stock as ‘Outperform’.

Analysis of Alto Neuroscience Inc (ANRO)

In order to gain a clear picture of Alto Neuroscience Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -38.04% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 22.53, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

An average volume of 305.73K can be a very valuable indicator of volatility for ANRO stock. On a monthly basis, the volatility of the stock is set at 8.10%, whereas on a weekly basis, it is put at 7.05%, with a gain of 2.17% over the past seven days. Furthermore, long-term investors anticipate a median target price of $11.43, showing growth from the present price of $2.35, which can serve as yet another indication of whether ANRO is worth investing in or should be passed over.

How Do You Analyze Alto Neuroscience Inc Shares?

In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 20.61%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 76.39% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Hot this week

Are M3 Brigade Acquisition V Corp (MBAV) shares a good deal now?

While M3 Brigade Acquisition V Corp has overperformed by...

Vanda Pharmaceuticals Inc (VNDA) requires closer examination

While Vanda Pharmaceuticals Inc has overperformed by 1.64%, investors...

Bandwidth Inc (BAND) shows promising results

While Bandwidth Inc has underperformed by -0.37%, investors are...

What was FormFactor Inc (FORM)’s performance in the last session?

While FormFactor Inc has underperformed by -0.50%, investors are...

Is International Seaways Inc (INSW) a good investment opportunity?

While International Seaways Inc has overperformed by 1.52%, investors...

Topics

Are M3 Brigade Acquisition V Corp (MBAV) shares a good deal now?

While M3 Brigade Acquisition V Corp has overperformed by...

Vanda Pharmaceuticals Inc (VNDA) requires closer examination

While Vanda Pharmaceuticals Inc has overperformed by 1.64%, investors...

Bandwidth Inc (BAND) shows promising results

While Bandwidth Inc has underperformed by -0.37%, investors are...

What was FormFactor Inc (FORM)’s performance in the last session?

While FormFactor Inc has underperformed by -0.50%, investors are...

Is International Seaways Inc (INSW) a good investment opportunity?

While International Seaways Inc has overperformed by 1.52%, investors...

Allient Inc (ALNT) presents a great opportunity, but the stock is slightly overvalued

While Allient Inc has overperformed by 1.81%, investors are...

Is it possible to buy Mission Produce Inc(AVO) shares at a good price now?

While Mission Produce Inc has overperformed by 0.50%, investors...

Examining MillerKnoll Inc (MLKN) stock is warranted

While MillerKnoll Inc has overperformed by 0.66%, investors are...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.